LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a
LONDON — The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the greatest need
Greetings from STAT’s London outpost, with reporter Andrew Joseph here filling in for Ed. No particularly exciting flavored coffee to offer you today, but we
LONDON — Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC Therapeutics, the companies said Monday.
LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic aspects of embryonic development, including
LONDON — An experimental cancer treatment from Roche failed to improve survival in a major lung cancer study, the company said Tuesday, a result that
LONDON — The incoming Trump administration and its embrace of anti-vaccine figures will give scientists and public health officials the chance to make the case
LONDON — The stacks of brightly colored disposable e-cigarettes, touting flavors like cotton candy ice and greengrape melon and often looming over the not-dissimilar-looking candy
LONDON — Robert F. Kennedy Jr. has been a vocal critic of the pharma industry. He’s said it’s corrupted U.S. health agencies and has attacked,
LONDON — Reversing an earlier decision, European regulators on Thursday recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved, saying that the